BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 36437221)

  • 1. High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot.
    Keam SP; Halse H; Nguyen T; Wang M; Van Kooten Losio N; Mitchell C; Caramia F; Byrne DJ; Haupt S; Ryland G; Darcy PK; Sandhu S; Blombery P; Haupt Y; Williams SG; Neeson PJ
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brachytherapy on-a-chip: a clinically-relevant approach for radiotherapy testing in 3d biology.
    Chermat R; Refet-Mollof E; Kamio Y; Carrier JF; Wong P; Gervais T
    Lab Chip; 2024 Apr; 24(8):2335-2346. PubMed ID: 38568477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer.
    Freiberger C; Berneking V; Vögeli TA; Kirschner-Hermanns R; Eble MJ; Pinkawa M
    Brachytherapy; 2018; 17(3):517-523. PubMed ID: 29496423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition.
    Pellizzon AC; Salvajoli J; Novaes P; Maia M; Fogaroli R; Gides D; Horriot R
    Int J Med Sci; 2008 Jun; 5(3):113-20. PubMed ID: 18566673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
    Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
    Yamazaki H; Masui K; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K
    Radiother Oncol; 2019 Mar; 132():162-170. PubMed ID: 30416045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer.
    Armstrong S; Tsang Y; Lowe G; Tharmalingam H; Alonzi R; Ostler P; Hughes R; Hoskin P
    Radiother Oncol; 2021 Apr; 157():93-98. PubMed ID: 33493500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "scoping" review of prostate brachytherapy and immune responses.
    Nguyen AT; Liu CS; Kamrava M
    Brachytherapy; 2023; 22(1):21-29. PubMed ID: 36437221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
    Zaorsky NG; Doyle LA; Hurwitz MD; Dicker AP; Den RB
    Expert Rev Anticancer Ther; 2014 Jan; 14(1):39-50. PubMed ID: 24124755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer.
    Zaorsky NG; Den RB; Doyle LA; Dicker AP; Hurwitz MD
    Expert Rev Med Devices; 2013 Nov; 10(6):751-63. PubMed ID: 24195459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose rate brachytherapy in the treatment of prostate cancer.
    Vicini F; Vargas C; Gustafson G; Edmundson G; Martinez A
    World J Urol; 2003 Sep; 21(4):220-8. PubMed ID: 12905008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose rate brachytherapy for men with localized prostate cancer.
    Peinemann F; Grouven U; Hemkens LG; Bartel C; Borchers H; Pinkawa M; Heidenreich A; Sauerland S
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008871. PubMed ID: 21735436
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.